Yuri Zarate
Concepts (415)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Matrix Attachment Region Binding Proteins | 17 | 2024 | 35 | 9.870 |
Why?
| Transcription Factors | 18 | 2024 | 564 | 7.050 |
Why?
| Phenotype | 26 | 2024 | 733 | 6.110 |
Why?
| Genetic Association Studies | 12 | 2024 | 116 | 4.480 |
Why?
| Intellectual Disability | 18 | 2023 | 124 | 4.100 |
Why?
| Mutation | 24 | 2024 | 1294 | 3.600 |
Why?
| Abnormalities, Multiple | 11 | 2021 | 167 | 3.170 |
Why?
| Syndrome | 20 | 2024 | 238 | 2.400 |
Why?
| Child, Preschool | 36 | 2024 | 3883 | 2.140 |
Why?
| Developmental Disabilities | 6 | 2021 | 119 | 1.960 |
Why?
| Genetic Diseases, Inborn | 3 | 2021 | 23 | 1.960 |
Why?
| Infant | 32 | 2021 | 3563 | 1.710 |
Why?
| Mutation, Missense | 7 | 2024 | 105 | 1.700 |
Why?
| Urogenital Abnormalities | 3 | 2019 | 17 | 1.650 |
Why?
| Male | 61 | 2024 | 25399 | 1.580 |
Why?
| Child | 34 | 2024 | 6851 | 1.490 |
Why?
| Humans | 86 | 2024 | 50208 | 1.480 |
Why?
| Craniofacial Abnormalities | 4 | 2024 | 27 | 1.380 |
Why?
| Female | 55 | 2024 | 26635 | 1.370 |
Why?
| Beckwith-Wiedemann Syndrome | 4 | 2014 | 7 | 1.270 |
Why?
| Cardiovascular Abnormalities | 3 | 2019 | 26 | 1.250 |
Why?
| Adolescent | 28 | 2024 | 6390 | 1.240 |
Why?
| Genetic Predisposition to Disease | 3 | 2021 | 509 | 1.230 |
Why?
| Marfan Syndrome | 4 | 2022 | 24 | 1.210 |
Why?
| Microcephaly | 3 | 2021 | 41 | 1.160 |
Why?
| Genotype | 5 | 2021 | 534 | 1.080 |
Why?
| Epilepsy | 4 | 2021 | 177 | 1.050 |
Why?
| Sequence Deletion | 3 | 2014 | 67 | 1.050 |
Why?
| Chromosomes, Human, Pair 2 | 3 | 2021 | 25 | 1.020 |
Why?
| Energy Metabolism | 3 | 2024 | 279 | 0.990 |
Why?
| Aortic Diseases | 2 | 2015 | 54 | 0.970 |
Why?
| Young Adult | 17 | 2021 | 3981 | 0.970 |
Why?
| Chromosome Deletion | 3 | 2021 | 140 | 0.950 |
Why?
| Branchial Region | 1 | 2024 | 4 | 0.950 |
Why?
| Infant, Newborn | 19 | 2024 | 2766 | 0.950 |
Why?
| Osteochondrodysplasias | 2 | 2021 | 13 | 0.880 |
Why?
| Nervous System Malformations | 2 | 2020 | 17 | 0.870 |
Why?
| Face | 3 | 2021 | 60 | 0.870 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 74 | 0.850 |
Why?
| Growth Charts | 1 | 2022 | 6 | 0.840 |
Why?
| Facies | 6 | 2021 | 35 | 0.790 |
Why?
| Williams Syndrome | 3 | 2020 | 26 | 0.790 |
Why?
| Failure to Thrive | 2 | 2021 | 18 | 0.780 |
Why?
| Craniosynostoses | 2 | 2021 | 32 | 0.770 |
Why?
| Infant, Newborn, Diseases | 1 | 2022 | 57 | 0.770 |
Why?
| Genomics | 2 | 2021 | 285 | 0.770 |
Why?
| Growth Disorders | 2 | 2019 | 64 | 0.760 |
Why?
| Genetics, Medical | 1 | 2020 | 5 | 0.750 |
Why?
| Noonan Syndrome | 3 | 2021 | 12 | 0.740 |
Why?
| Leukoencephalopathies | 2 | 2020 | 14 | 0.740 |
Why?
| Sulfatases | 1 | 2020 | 6 | 0.730 |
Why?
| Genetic Variation | 1 | 2021 | 213 | 0.700 |
Why?
| Language Development Disorders | 2 | 2020 | 17 | 0.680 |
Why?
| alpha-Galactosidase | 2 | 2009 | 9 | 0.670 |
Why?
| Aorta | 3 | 2020 | 162 | 0.670 |
Why?
| Adult | 23 | 2024 | 13324 | 0.670 |
Why?
| Fabry Disease | 2 | 2009 | 9 | 0.670 |
Why?
| Mouth Diseases | 1 | 2019 | 5 | 0.660 |
Why?
| Receptors, GABA-B | 1 | 2019 | 11 | 0.660 |
Why?
| Speech | 1 | 2019 | 52 | 0.660 |
Why?
| Epilepsy, Absence | 1 | 2019 | 11 | 0.650 |
Why?
| Dental Pulp Cavity | 1 | 2018 | 6 | 0.650 |
Why?
| Tooth Abnormalities | 1 | 2018 | 12 | 0.640 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 157 | 0.630 |
Why?
| Language | 1 | 2019 | 134 | 0.630 |
Why?
| Congenital Abnormalities | 2 | 2019 | 112 | 0.630 |
Why?
| Brain | 3 | 2016 | 1328 | 0.620 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 140 | 0.620 |
Why?
| Mosaicism | 2 | 2015 | 18 | 0.610 |
Why?
| Feeding Behavior | 1 | 2019 | 177 | 0.600 |
Why?
| Craniotomy | 1 | 2017 | 25 | 0.600 |
Why?
| Genetic Testing | 4 | 2016 | 119 | 0.590 |
Why?
| Microtubule-Associated Proteins | 2 | 2021 | 67 | 0.580 |
Why?
| Chromosomes, Human, X | 2 | 2015 | 19 | 0.560 |
Why?
| Acidosis | 1 | 2016 | 40 | 0.560 |
Why?
| Thalamus | 1 | 2016 | 36 | 0.550 |
Why?
| Hand Deformities, Congenital | 1 | 2016 | 5 | 0.550 |
Why?
| Micrognathism | 1 | 2016 | 3 | 0.550 |
Why?
| Brain Stem | 1 | 2016 | 57 | 0.550 |
Why?
| Child Development | 2 | 2010 | 191 | 0.550 |
Why?
| Cafe-au-Lait Spots | 1 | 2016 | 2 | 0.540 |
Why?
| Mitochondrial Diseases | 1 | 2016 | 42 | 0.540 |
Why?
| Neurocutaneous Syndromes | 1 | 2016 | 6 | 0.540 |
Why?
| Lactic Acid | 1 | 2016 | 76 | 0.540 |
Why?
| Fractures, Bone | 2 | 2019 | 106 | 0.540 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 40 | 0.530 |
Why?
| Brain Diseases | 3 | 2021 | 82 | 0.530 |
Why?
| Hemizygote | 1 | 2015 | 6 | 0.530 |
Why?
| Osteogenesis Imperfecta | 1 | 2016 | 38 | 0.530 |
Why?
| Genetic Diseases, X-Linked | 1 | 2015 | 7 | 0.530 |
Why?
| Iron Metabolism Disorders | 1 | 2015 | 7 | 0.530 |
Why?
| Neuroaxonal Dystrophies | 1 | 2015 | 8 | 0.520 |
Why?
| Neck | 1 | 2016 | 100 | 0.510 |
Why?
| Collagen Type I | 1 | 2016 | 88 | 0.510 |
Why?
| Hypertelorism | 1 | 2015 | 4 | 0.510 |
Why?
| Syndactyly | 1 | 2015 | 4 | 0.510 |
Why?
| Toes | 1 | 2015 | 14 | 0.500 |
Why?
| Anal Canal | 1 | 2015 | 21 | 0.500 |
Why?
| Receptor, Notch1 | 1 | 2014 | 4 | 0.490 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 411 | 0.490 |
Why?
| Muscle Hypotonia | 2 | 2017 | 21 | 0.490 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2014 | 19 | 0.490 |
Why?
| Chromosome Disorders | 1 | 2015 | 35 | 0.490 |
Why?
| Cleft Lip | 2 | 2018 | 40 | 0.490 |
Why?
| Congenital Hyperinsulinism | 1 | 2014 | 2 | 0.490 |
Why?
| Uniparental Disomy | 1 | 2014 | 11 | 0.490 |
Why?
| Peptide Elongation Factors | 1 | 2014 | 2 | 0.480 |
Why?
| Ribonucleoprotein, U5 Small Nuclear | 1 | 2014 | 2 | 0.480 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2014 | 55 | 0.480 |
Why?
| Chromosome Duplication | 1 | 2014 | 7 | 0.480 |
Why?
| Mandibulofacial Dysostosis | 1 | 2014 | 4 | 0.480 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 2014 | 29 | 0.470 |
Why?
| Child Abuse | 1 | 2016 | 136 | 0.470 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2014 | 36 | 0.470 |
Why?
| Carrier Proteins | 1 | 2015 | 306 | 0.460 |
Why?
| Dentofacial Deformities | 1 | 2013 | 1 | 0.460 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2013 | 19 | 0.450 |
Why?
| raf Kinases | 1 | 2013 | 4 | 0.450 |
Why?
| Nuclear Proteins | 3 | 2021 | 243 | 0.450 |
Why?
| Hypoplastic Left Heart Syndrome | 1 | 2014 | 93 | 0.440 |
Why?
| DNA-Binding Proteins | 1 | 2016 | 428 | 0.440 |
Why?
| Cerebrovascular Disorders | 1 | 2013 | 55 | 0.440 |
Why?
| Signal Transduction | 2 | 2023 | 1622 | 0.440 |
Why?
| Exome | 4 | 2017 | 46 | 0.430 |
Why?
| Kidney | 2 | 2015 | 672 | 0.420 |
Why?
| Heterozygote | 5 | 2021 | 81 | 0.410 |
Why?
| Trisomy | 2 | 2014 | 31 | 0.410 |
Why?
| Heart Defects, Congenital | 2 | 2015 | 585 | 0.400 |
Why?
| Retrospective Studies | 10 | 2022 | 6134 | 0.400 |
Why?
| Sex Chromosome Disorders of Sex Development | 1 | 2010 | 3 | 0.380 |
Why?
| Sex Chromosome Aberrations | 1 | 2010 | 8 | 0.380 |
Why?
| Acrocephalosyndactylia | 1 | 2010 | 2 | 0.360 |
Why?
| Digestive System Abnormalities | 1 | 2010 | 6 | 0.360 |
Why?
| Intestinal Volvulus | 1 | 2010 | 6 | 0.360 |
Why?
| Growth | 1 | 2010 | 40 | 0.350 |
Why?
| Nephrosis, Lipoid | 1 | 2009 | 5 | 0.350 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 20 | 0.350 |
Why?
| Jejunum | 1 | 2010 | 54 | 0.350 |
Why?
| Fetofetal Transfusion | 1 | 2009 | 6 | 0.340 |
Why?
| Melanosomes | 1 | 2009 | 1 | 0.340 |
Why?
| Vomiting | 1 | 2010 | 75 | 0.340 |
Why?
| Pigmentation Disorders | 1 | 2009 | 5 | 0.340 |
Why?
| Hyperplasia | 1 | 2009 | 96 | 0.330 |
Why?
| Skin Pigmentation | 1 | 2009 | 11 | 0.330 |
Why?
| Melanocytes | 1 | 2009 | 38 | 0.330 |
Why?
| Autistic Disorder | 4 | 2024 | 120 | 0.330 |
Why?
| Translocation, Genetic | 1 | 2010 | 264 | 0.330 |
Why?
| Radiography, Panoramic | 2 | 2019 | 9 | 0.330 |
Why?
| Diagnosis, Differential | 4 | 2016 | 1043 | 0.320 |
Why?
| Animals | 8 | 2024 | 13246 | 0.320 |
Why?
| In Situ Hybridization, Fluorescence | 3 | 2014 | 259 | 0.310 |
Why?
| Hearing Loss, Sensorineural | 1 | 2009 | 75 | 0.310 |
Why?
| Fetus | 1 | 2009 | 216 | 0.300 |
Why?
| Glucose Transport Proteins, Facilitative | 2 | 2018 | 10 | 0.300 |
Why?
| Skin Diseases, Genetic | 2 | 2018 | 9 | 0.300 |
Why?
| Haploinsufficiency | 2 | 2024 | 14 | 0.290 |
Why?
| Tumor Suppressor Proteins | 2 | 2020 | 128 | 0.290 |
Why?
| Joint Instability | 2 | 2018 | 40 | 0.290 |
Why?
| Arteries | 2 | 2018 | 92 | 0.290 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2007 | 54 | 0.280 |
Why?
| Comparative Genomic Hybridization | 3 | 2020 | 47 | 0.280 |
Why?
| Intelligence | 1 | 2007 | 59 | 0.280 |
Why?
| Magnetic Resonance Imaging | 4 | 2020 | 1541 | 0.270 |
Why?
| Magnetic Resonance Angiography | 2 | 2017 | 76 | 0.270 |
Why?
| Echocardiography | 4 | 2020 | 375 | 0.270 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2019 | 485 | 0.260 |
Why?
| Alkaline Phosphatase | 2 | 2023 | 95 | 0.260 |
Why?
| Vascular Malformations | 2 | 2018 | 98 | 0.260 |
Why?
| Cleft Palate | 2 | 2018 | 78 | 0.260 |
Why?
| Body Weight | 2 | 2022 | 512 | 0.250 |
Why?
| Alleles | 2 | 2016 | 251 | 0.250 |
Why?
| Cerebellum | 3 | 2021 | 135 | 0.240 |
Why?
| Pseudohypoaldosteronism | 1 | 2024 | 5 | 0.240 |
Why?
| Receptors, Mineralocorticoid | 1 | 2024 | 9 | 0.240 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2017 | 11 | 0.240 |
Why?
| Reproducibility of Results | 2 | 2022 | 1185 | 0.240 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 170 | 0.240 |
Why?
| Mandible | 1 | 2024 | 21 | 0.230 |
Why?
| Zebrafish | 2 | 2021 | 55 | 0.230 |
Why?
| Gene Deletion | 3 | 2024 | 270 | 0.220 |
Why?
| Drosophila Proteins | 1 | 2023 | 25 | 0.220 |
Why?
| Comorbidity | 2 | 2015 | 613 | 0.220 |
Why?
| Absorptiometry, Photon | 1 | 2023 | 153 | 0.220 |
Why?
| Lymphopenia | 1 | 2023 | 18 | 0.220 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2023 | 56 | 0.210 |
Why?
| Pedigree | 3 | 2020 | 125 | 0.210 |
Why?
| Color Vision Defects | 1 | 2022 | 1 | 0.210 |
Why?
| Rod Opsins | 1 | 2022 | 1 | 0.210 |
Why?
| Microarray Analysis | 2 | 2014 | 73 | 0.210 |
Why?
| Guanine Nucleotide Exchange Factors | 2 | 2023 | 18 | 0.200 |
Why?
| Costello Syndrome | 1 | 2021 | 1 | 0.200 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2023 | 198 | 0.200 |
Why?
| Argonaute Proteins | 1 | 2021 | 11 | 0.200 |
Why?
| Ectodermal Dysplasia | 1 | 2021 | 6 | 0.200 |
Why?
| Nervous System Diseases | 1 | 2023 | 89 | 0.200 |
Why?
| Kidney Diseases, Cystic | 1 | 2021 | 19 | 0.200 |
Why?
| Eye Abnormalities | 1 | 2021 | 25 | 0.200 |
Why?
| Exons | 3 | 2020 | 95 | 0.200 |
Why?
| Mice, Knockout | 1 | 2024 | 846 | 0.190 |
Why?
| Bone Density | 1 | 2023 | 379 | 0.190 |
Why?
| Ventricular Dysfunction, Left | 1 | 2022 | 94 | 0.190 |
Why?
| Collagen Type V | 1 | 2021 | 4 | 0.190 |
Why?
| Dwarfism | 1 | 2021 | 4 | 0.190 |
Why?
| Collagen Type III | 1 | 2021 | 7 | 0.190 |
Why?
| Synaptosomal-Associated Protein 25 | 1 | 2020 | 4 | 0.190 |
Why?
| Registries | 2 | 2021 | 522 | 0.190 |
Why?
| Latin America | 1 | 2020 | 9 | 0.190 |
Why?
| Cardiomyopathies | 1 | 2022 | 116 | 0.190 |
Why?
| Cyclin-Dependent Kinases | 1 | 2021 | 28 | 0.190 |
Why?
| Thinness | 1 | 2021 | 45 | 0.190 |
Why?
| Myofibromatosis | 1 | 2020 | 2 | 0.180 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 36 | 0.180 |
Why?
| Blepharophimosis | 1 | 2020 | 4 | 0.180 |
Why?
| Sulfotransferases | 1 | 2020 | 40 | 0.180 |
Why?
| Sleep Stages | 1 | 2020 | 45 | 0.180 |
Why?
| Diacylglycerol O-Acyltransferase | 1 | 2019 | 5 | 0.180 |
Why?
| Prevalence | 3 | 2022 | 951 | 0.170 |
Why?
| Age of Onset | 1 | 2020 | 107 | 0.170 |
Why?
| Japan | 1 | 2019 | 26 | 0.170 |
Why?
| Bone and Bones | 1 | 2023 | 475 | 0.170 |
Why?
| Social Behavior Disorders | 1 | 2019 | 6 | 0.170 |
Why?
| Apraxias | 1 | 2019 | 9 | 0.170 |
Why?
| Abnormalities, Radiation-Induced | 1 | 2019 | 7 | 0.170 |
Why?
| Codon, Terminator | 1 | 2019 | 8 | 0.170 |
Why?
| Hypophosphatasia | 1 | 2019 | 8 | 0.170 |
Why?
| Diarrhea | 1 | 2019 | 92 | 0.170 |
Why?
| Dilatation, Pathologic | 2 | 2017 | 23 | 0.170 |
Why?
| Body Mass Index | 1 | 2022 | 656 | 0.170 |
Why?
| Hypertension, Pulmonary | 1 | 2021 | 121 | 0.160 |
Why?
| Gestational Age | 1 | 2021 | 418 | 0.160 |
Why?
| Child Behavior Disorders | 1 | 2019 | 79 | 0.160 |
Why?
| Radiography, Dental | 1 | 2018 | 5 | 0.160 |
Why?
| Trans-Activators | 1 | 2020 | 134 | 0.160 |
Why?
| Gene Rearrangement | 1 | 2019 | 74 | 0.160 |
Why?
| Cell Nucleus | 1 | 2019 | 187 | 0.160 |
Why?
| Malnutrition | 1 | 2019 | 87 | 0.160 |
Why?
| Cystic Fibrosis | 1 | 2021 | 149 | 0.160 |
Why?
| Pierre Robin Syndrome | 1 | 2018 | 6 | 0.160 |
Why?
| Lip | 1 | 2018 | 11 | 0.160 |
Why?
| Mice | 3 | 2024 | 5759 | 0.160 |
Why?
| Electroencephalography | 1 | 2020 | 307 | 0.160 |
Why?
| Genes, X-Linked | 2 | 2020 | 7 | 0.150 |
Why?
| Inheritance Patterns | 1 | 2018 | 22 | 0.150 |
Why?
| Motor Activity | 1 | 2019 | 229 | 0.150 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 8 | 0.150 |
Why?
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 18 | 0.150 |
Why?
| Hernia, Diaphragmatic | 1 | 2018 | 22 | 0.150 |
Why?
| Cysts | 1 | 2018 | 51 | 0.150 |
Why?
| Myopia | 1 | 2017 | 8 | 0.150 |
Why?
| Keratoconus | 1 | 2017 | 4 | 0.150 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2018 | 52 | 0.150 |
Why?
| Phosphorylation | 1 | 2019 | 534 | 0.150 |
Why?
| Prospective Studies | 1 | 2023 | 2379 | 0.150 |
Why?
| Communication | 1 | 2019 | 246 | 0.150 |
Why?
| Cornea | 1 | 2017 | 52 | 0.140 |
Why?
| Histones | 1 | 2019 | 313 | 0.140 |
Why?
| Glutamate-tRNA Ligase | 1 | 2016 | 4 | 0.140 |
Why?
| Fibroblasts | 2 | 2020 | 351 | 0.140 |
Why?
| Endoscopy | 1 | 2017 | 124 | 0.140 |
Why?
| Pathology, Molecular | 1 | 2016 | 22 | 0.140 |
Why?
| Osteoblasts | 1 | 2019 | 450 | 0.140 |
Why?
| Liver Diseases | 1 | 2016 | 78 | 0.130 |
Why?
| Population Surveillance | 1 | 2016 | 164 | 0.130 |
Why?
| Germ-Line Mutation | 1 | 2015 | 61 | 0.130 |
Why?
| Frameshift Mutation | 1 | 2015 | 17 | 0.130 |
Why?
| Aneuploidy | 1 | 2015 | 16 | 0.130 |
Why?
| Skin | 2 | 2018 | 415 | 0.130 |
Why?
| Codon, Nonsense | 1 | 2015 | 26 | 0.130 |
Why?
| Arkansas | 2 | 2019 | 1985 | 0.130 |
Why?
| Multicystic Dysplastic Kidney | 1 | 2014 | 1 | 0.120 |
Why?
| Ring Chromosomes | 1 | 2014 | 7 | 0.120 |
Why?
| Anus, Imperforate | 1 | 2014 | 8 | 0.120 |
Why?
| Disorders of Sex Development | 1 | 2014 | 7 | 0.120 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2014 | 38 | 0.120 |
Why?
| Heart Valve Diseases | 1 | 2015 | 47 | 0.120 |
Why?
| Karyotyping | 1 | 2014 | 83 | 0.120 |
Why?
| Sequence Analysis, DNA | 1 | 2015 | 238 | 0.120 |
Why?
| Aortic Aneurysm | 1 | 2014 | 25 | 0.120 |
Why?
| Aortic Valve | 1 | 2015 | 112 | 0.110 |
Why?
| Amino Acid Sequence | 3 | 2021 | 586 | 0.110 |
Why?
| Disease Models, Animal | 1 | 2019 | 1458 | 0.110 |
Why?
| Chromosome Mapping | 1 | 2014 | 156 | 0.110 |
Why?
| Pregnancy | 4 | 2019 | 2604 | 0.110 |
Why?
| Cohort Studies | 4 | 2020 | 1422 | 0.110 |
Why?
| Tomography Scanners, X-Ray Computed | 1 | 2013 | 12 | 0.110 |
Why?
| Chromosome Aberrations | 1 | 2015 | 297 | 0.110 |
Why?
| Time Factors | 1 | 2019 | 2922 | 0.110 |
Why?
| DNA Copy Number Variations | 1 | 2012 | 110 | 0.100 |
Why?
| Macroglossia | 1 | 2012 | 1 | 0.100 |
Why?
| Severity of Illness Index | 1 | 2015 | 951 | 0.100 |
Why?
| Genes, Neurofibromatosis 1 | 1 | 2011 | 3 | 0.100 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2011 | 6 | 0.100 |
Why?
| Neurofibromatoses | 1 | 2011 | 5 | 0.100 |
Why?
| Genitalia | 1 | 2010 | 11 | 0.090 |
Why?
| Duodenogastric Reflux | 1 | 2010 | 1 | 0.090 |
Why?
| Cephalometry | 1 | 2010 | 17 | 0.090 |
Why?
| Delayed Diagnosis | 1 | 2010 | 23 | 0.090 |
Why?
| Hospitalization | 1 | 2014 | 655 | 0.090 |
Why?
| Kidney Function Tests | 1 | 2009 | 49 | 0.090 |
Why?
| Podocytes | 1 | 2009 | 19 | 0.090 |
Why?
| Kidney Glomerulus | 1 | 2009 | 39 | 0.090 |
Why?
| alpha-Fetoproteins | 1 | 2009 | 15 | 0.090 |
Why?
| Intestinal Obstruction | 1 | 2010 | 36 | 0.090 |
Why?
| Twins, Monozygotic | 1 | 2009 | 17 | 0.080 |
Why?
| Hair Color | 1 | 2009 | 10 | 0.080 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2009 | 12 | 0.080 |
Why?
| Steroids | 1 | 2009 | 57 | 0.080 |
Why?
| Melanins | 1 | 2009 | 27 | 0.080 |
Why?
| Creatinine | 1 | 2009 | 141 | 0.080 |
Why?
| Confidence Intervals | 1 | 2009 | 156 | 0.080 |
Why?
| Age Distribution | 1 | 2009 | 168 | 0.080 |
Why?
| RNA, Messenger | 2 | 2023 | 1108 | 0.080 |
Why?
| Acute Disease | 1 | 2009 | 368 | 0.080 |
Why?
| Anti-Inflammatory Agents | 1 | 2009 | 160 | 0.080 |
Why?
| Radiography | 1 | 2009 | 491 | 0.080 |
Why?
| Patient Compliance | 1 | 2009 | 230 | 0.080 |
Why?
| Microfilament Proteins | 1 | 2007 | 43 | 0.070 |
Why?
| Immunotherapy | 1 | 2009 | 240 | 0.070 |
Why?
| Ultrasonography | 1 | 2009 | 437 | 0.070 |
Why?
| Chromosome Banding | 1 | 2007 | 24 | 0.070 |
Why?
| Risk Factors | 1 | 2015 | 3629 | 0.070 |
Why?
| Age Factors | 1 | 2010 | 1092 | 0.070 |
Why?
| Sex Factors | 1 | 2008 | 697 | 0.070 |
Why?
| Case-Control Studies | 1 | 2009 | 1126 | 0.070 |
Why?
| Vitamins | 1 | 2024 | 64 | 0.060 |
Why?
| Liver | 1 | 2009 | 1116 | 0.060 |
Why?
| Ligases | 1 | 2023 | 10 | 0.060 |
Why?
| Agenesis of Corpus Callosum | 1 | 2023 | 10 | 0.060 |
Why?
| Drosophila | 1 | 2023 | 17 | 0.060 |
Why?
| Ubiquitins | 1 | 2023 | 39 | 0.050 |
Why?
| Corpus Callosum | 1 | 2023 | 28 | 0.050 |
Why?
| Prognosis | 2 | 2019 | 1954 | 0.050 |
Why?
| Retinal Cone Photoreceptor Cells | 1 | 2022 | 1 | 0.050 |
Why?
| Multigene Family | 1 | 2022 | 56 | 0.050 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2023 | 95 | 0.050 |
Why?
| Caenorhabditis elegans | 1 | 2023 | 138 | 0.050 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2023 | 117 | 0.050 |
Why?
| Cilia | 1 | 2021 | 6 | 0.050 |
Why?
| Hedgehog Proteins | 1 | 2021 | 33 | 0.050 |
Why?
| Proteomics | 1 | 2024 | 330 | 0.050 |
Why?
| Transcriptional Elongation Factors | 1 | 2021 | 18 | 0.050 |
Why?
| Stroke Volume | 1 | 2022 | 129 | 0.050 |
Why?
| Protein Stability | 1 | 2021 | 44 | 0.050 |
Why?
| Gene Frequency | 1 | 2021 | 94 | 0.050 |
Why?
| NF-kappa B | 1 | 2023 | 315 | 0.050 |
Why?
| Retina | 1 | 2021 | 65 | 0.050 |
Why?
| Ventricular Function, Left | 1 | 2022 | 159 | 0.050 |
Why?
| Evolution, Molecular | 1 | 2021 | 99 | 0.050 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2020 | 47 | 0.050 |
Why?
| Sinus of Valsalva | 1 | 2020 | 7 | 0.050 |
Why?
| Histone Acetyltransferases | 1 | 2020 | 22 | 0.040 |
Why?
| Aneurysm | 1 | 2020 | 33 | 0.040 |
Why?
| Basilar Artery | 1 | 2020 | 7 | 0.040 |
Why?
| Nonsense Mediated mRNA Decay | 1 | 2020 | 5 | 0.040 |
Why?
| Models, Molecular | 1 | 2021 | 341 | 0.040 |
Why?
| Cell Nucleus Shape | 1 | 2019 | 1 | 0.040 |
Why?
| Growth and Development | 1 | 2019 | 15 | 0.040 |
Why?
| Carotid Arteries | 1 | 2020 | 85 | 0.040 |
Why?
| Speech Disorders | 1 | 2019 | 16 | 0.040 |
Why?
| Truncus Arteriosus | 1 | 2019 | 8 | 0.040 |
Why?
| Live Birth | 1 | 2019 | 23 | 0.040 |
Why?
| Radioactive Hazard Release | 1 | 2019 | 14 | 0.040 |
Why?
| Amino Acids | 1 | 2021 | 362 | 0.040 |
Why?
| Pregnancy, Multiple | 1 | 2019 | 23 | 0.040 |
Why?
| Behavior | 1 | 2019 | 46 | 0.040 |
Why?
| Enzyme Replacement Therapy | 1 | 2019 | 17 | 0.040 |
Why?
| Sequence Homology | 1 | 2019 | 20 | 0.040 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 181 | 0.040 |
Why?
| Parturition | 1 | 2019 | 51 | 0.040 |
Why?
| Micronesia | 1 | 2019 | 111 | 0.040 |
Why?
| Fatal Outcome | 2 | 2011 | 195 | 0.040 |
Why?
| Nerve Tissue Proteins | 1 | 2020 | 193 | 0.040 |
Why?
| Imaging, Three-Dimensional | 1 | 2020 | 153 | 0.040 |
Why?
| Seizures | 1 | 2020 | 196 | 0.040 |
Why?
| Cataract | 1 | 2019 | 45 | 0.040 |
Why?
| Interferon Regulatory Factors | 1 | 2018 | 17 | 0.040 |
Why?
| Protein Kinase Inhibitors | 1 | 2020 | 206 | 0.040 |
Why?
| Cell Cycle | 1 | 2019 | 232 | 0.040 |
Why?
| Smad2 Protein | 1 | 2018 | 6 | 0.040 |
Why?
| Connective Tissue Growth Factor | 1 | 2018 | 8 | 0.040 |
Why?
| Prader-Willi Syndrome | 1 | 2017 | 7 | 0.040 |
Why?
| Tongue | 1 | 2018 | 39 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2020 | 863 | 0.040 |
Why?
| Ataxia | 1 | 2017 | 20 | 0.040 |
Why?
| Conserved Sequence | 1 | 2017 | 56 | 0.040 |
Why?
| Corneal Topography | 1 | 2017 | 6 | 0.040 |
Why?
| Corneal Pachymetry | 1 | 2017 | 5 | 0.040 |
Why?
| Learning | 1 | 2019 | 159 | 0.040 |
Why?
| Transforming Growth Factor beta | 1 | 2018 | 144 | 0.040 |
Why?
| Tomography, Optical Coherence | 1 | 2017 | 102 | 0.030 |
Why?
| Osteogenesis | 1 | 2019 | 353 | 0.030 |
Why?
| Cell Line | 1 | 2019 | 1021 | 0.030 |
Why?
| Cell Differentiation | 1 | 2019 | 650 | 0.030 |
Why?
| Pain | 1 | 2019 | 381 | 0.030 |
Why?
| Models, Biological | 1 | 2019 | 723 | 0.030 |
Why?
| Biopsy | 1 | 2018 | 590 | 0.030 |
Why?
| Cell Proliferation | 1 | 2019 | 1013 | 0.030 |
Why?
| Hospital Charges | 1 | 2014 | 44 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2019 | 979 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2020 | 1161 | 0.030 |
Why?
| Hospitals, Pediatric | 1 | 2014 | 236 | 0.030 |
Why?
| Hospital Mortality | 1 | 2014 | 407 | 0.030 |
Why?
| Pregnancy, Twin | 1 | 2012 | 8 | 0.030 |
Why?
| Diseases in Twins | 1 | 2012 | 15 | 0.030 |
Why?
| Cardiac Surgical Procedures | 1 | 2014 | 295 | 0.020 |
Why?
| Diabetes, Gestational | 1 | 2012 | 52 | 0.020 |
Why?
| Length of Stay | 1 | 2014 | 621 | 0.020 |
Why?
| Thymine | 1 | 2007 | 10 | 0.020 |
Why?
| Contracture | 1 | 2007 | 19 | 0.020 |
Why?
| Musculoskeletal Abnormalities | 1 | 2007 | 13 | 0.020 |
Why?
| Cytosine | 1 | 2007 | 30 | 0.020 |
Why?
| Early Diagnosis | 1 | 2007 | 87 | 0.020 |
Why?
| Prenatal Diagnosis | 1 | 2007 | 105 | 0.020 |
Why?
| Middle Aged | 1 | 2020 | 12206 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 2007 | 443 | 0.010 |
Why?
|
|
Zarate's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|